Search

Your search keyword '"Silverman, Gregg J."' showing total 491 results

Search Constraints

Start Over You searched for: Author "Silverman, Gregg J." Remove constraint Author: "Silverman, Gregg J."
491 results on '"Silverman, Gregg J."'

Search Results

3. Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination

4. Depressed serum IgM levels in SLE are restricted to defined subgroups

5. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis

7. Impaired immune responses in the airways are associated with poor outcome in critically ill COVID-19 patients

8. miRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation.

9. Dietary tryptophan and genetic susceptibility expand gut microbiota that promote systemic autoimmune activation

12. Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares

15. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

16. Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo

17. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

23. Hybrid and vaccine‐induced immunity against SAR‐CoV ‐2 in MS patients on different disease‐modifying therapies

29. Lupus disease flares are concordant with immune responses to blooms of lipoglycan-expressing Ruminococcus blautia gnavus strains arising from unstable gut microbiota communities

30. Humoral and Cellular Responses to SARS-CoV-2 Vaccines in MS Patients on Ocrelizumab and Other Disease-modifying Therapies: A Prospective Study From NYU Multiple Sclerosis Care Center (P1-1.Virtual)

33. Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study

40. Lupus Gut Microbiota Transplants Cause Autoimmunity and Inflammation

47. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

Catalog

Books, media, physical & digital resources